The expression of HLA-E/HLA-DRA was upregulated (Fig. 5g), and significant enrichment of IFNG pathway were observed in responsive tumor samples (Supplementary Fig. 2f), which may account for the increased T cell infiltration22 after neoadjuvant treatment. This evidence concerns the gene HLA-DRA and neoplasm.